An Assessment of Medication Errors Among Pediatric Patients in Three Hospitals in Freetown Sierra Leone: Findings and Implications for a Low-Income Country

References

• National Coordination Council for Medication Error Reporting and Prevention (NCCMERP). About medication errors: what is a medication? 2023. Available from: https://www.nccmerp.org/about-medication-errors. Accessed May 30, 2021.
   Google Scholar
• Manias E, Cranswick N, Newall F, et al. Medication error trends and effects of person‐related, environment‐related, and communication-related factors on medication errors in a pediatric hospital. J Pediatric Child Health. 2019;55(3):320–326. doi:10.1111/jpc.14193
   PubMed Web of Science ®Google Scholar
• Rinke ML, Bundy DG, Velasquez CA, et al. Interventions to reduce pediatric medication errors: a systematic review. Pediatrics. 2014;134(2):338–360. doi:10.1542/peds.2013-3531
   PubMed Web of Science ®Google Scholar
• Kacew S, Lock S. Developmental aspects of pediatric pharmacology and toxicology. In: Drug Toxicity and Metabolism in Pediatrics. CRC Press; 2018:1–14.
   Google Scholar
• Ghaleb MA, Barber N, Franklin BD, Yeung VW, Khaki ZF, Wong IC. Systematic review of medication errors in pediatric patients. Ann Pharmacother. 2006;40(10):1766–1776. doi:10.1345/aph.1G717
   PubMed Web of Science ®Google Scholar
• Kozer E, Berkovitch M, Koren G. Medication errors in children. Pediatr Clinics. 2006;53(6):1155–1168. doi:10.1016/j.pcl.2006.09.005
   PubMed Web of Science ®Google Scholar
• D’Errico S, Zanon M, Radaelli D, et al. Medication errors in pediatrics: proposals to improve the quality and safety of care through clinical risk management. Front Med. 2022;8:814100. doi:10.3389/fmed.2021.814100
   Web of Science ®Google Scholar
• Billstein-Leber M, Carrillo COLJD, Cassano AT, et al. ASHP guidelines on preventing medication errors in hospitals. ASHP guidelines on preventing medication errors in hospitals. Am J Health-Syst Pharm. 2018;75(19):1493–1517. doi:10.2146/ajhp170811
   PubMed Web of Science ®Google Scholar
• World Health Organization. Reporting and learning systems for medication errors: the role of pharmacovigilance centers; 2014. Available from: https://apps.who.int/iris/bitstream/handle/10665/137036/9789241507943_eng.pdf. Accessed May 30, 2021.
   Google Scholar
• Pharmacy Board of Sierra Leone (PBSL). Pharmacy and drugs act 2001. Available from: http://www.sierra-leone.org/Laws/2001-12.pdf. Accessed April 20, 2021.
   Google Scholar
• De Vries THR, Hogerzeil HV. Fresle D guide to good prescribing: a practical manual. World Health Organization; 1994. Available from: https://apps.who.int/iris/bitstream/handle/10665/59001/WHO_DAP_94.11.pdf. Accessed April 20, 2021.
   Google Scholar
• Ragaven LB, Nkera-Gutabara JG. Adherence to prescription-writing guidelines for outpatients in Southern Gauteng district hospitals. Afr J Prim Health Care Fam Med. 2020;12(1):1–11.
   Web of Science ®Google Scholar
• Barbour E, Hughes J, Gill D. P11 improving the completion of the medication prescription and administration record on a pediatric ward. Paper presented at: Neonatal and Paediatric Pharmacists Group 22nd Annual Conference, 4–6 November 2016; 2018; Birmingham: St John’s Hotel.
   Google Scholar
• Shimelis D. Quality of pediatric prescription writing at Department of Pediatrics and Child Health, Tikur Anbessa Specialized Teaching Hospital, Addis Ababa, Ethiopia. Ethiop J Ped Child Health. 2015;11(1):37–45.
   Google Scholar
• Abdellah AE, Abdelrahman SM. Prescription writing quality in pediatric teaching hospitals in Khartoum. Sudan J Paediatr. 2012;12(1):64.
   PubMedGoogle Scholar
• Azar C, Allué D, Valnet-Rabier MB, et al. Patterns of medication errors involving pediatric population reported to the French Medication Error Guichet. Pharm Pract. 2021;19(2):2360. doi:10.18549/PharmPract.2021.2.2360
   PubMed Web of Science ®Google Scholar
• Conn RL, Tully MP, Shields MD, Carrington A, Dornan T. Characteristics of reported pediatric medication errors in Northern Ireland and use in quality improvement. Pediatr Drugs. 2020;22:551–560. doi:10.1007/s40272-020-00407-1
   PubMed Web of Science ®Google Scholar
• Gates PJ, Baysari MT, Gazarian M, Raban MZ, Meyerson S, Westbrook JI. Prevalence of medication errors among pediatric inpatients: systematic review and meta-analysis. Drug Safety. 2019;42:1329–1342. doi:10.1007/s40264-019-00850-1
   PubMed Web of Science ®Google Scholar
• Alghamdi AA, Keers RN, Sutherland A, Ashcroft DM. Prevalence and nature of medication errors and preventable adverse drug events in pediatric and neonatal intensive care settings: a systematic review. Drug Safety. 2019;42:1423–1436. doi:10.1007/s40264-019-00856-9
   PubMed Web of Science ®Google Scholar
• Bebitoğlu BT, Oğuz E, Nuhoğlu Ç, et al. Evaluation of potential drug-drug interactions in a pediatric population. Turk Arch Pediatr. 2020;55(1):30.
   Google Scholar
• Feinstein J, Dai D, Zhong W, Freedman J, Feudtner C. Potential drug-drug interactions in infant, child, and adolescent patients in Children’s hospitals. Pediatrics. 2015;135(1):e99–e108. doi:10.1542/peds.2014-2015
   PubMed Web of Science ®Google Scholar
• Rao C, Shenoy V, Udaykumar P. Potential drug–drug interactions in the pediatric intensive care unit of a tertiary care hospital. J Pharmacol Pharmacotherapeutics. 2019;10(2):63–68. doi:10.4103/jpp.JPP_27_19
   Web of Science ®Google Scholar
• Oshikoya KA, Oreagba IA, Godman B, et al. Potential drug-drug interactions in pediatric outpatient prescriptions in Nigeria and implications for the future. Expert Rev Clin Pharmacol. 2016;9(11):1505–1515. doi:10.1080/17512433.2016.1232619
   PubMed Web of Science ®Google Scholar
• Rodrigues MCS, Oliveira C. Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review. Rev Lat Am Enfermagem. 2016;24. doi:10.1590/1518-8345.1316.2800
   Web of Science ®Google Scholar
• Chiatti C, Bustacchini S, Furneri G, et al. The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review. Drug Safety. 2012;35(S1):73–87. doi:10.1007/BF03319105
   PubMedGoogle Scholar
• Elliott RA, Camacho E, Jankovic D, Sculpher MJ, Faria R. Economic analysis of the prevalence and clinical and economic burden of medication error in England. BMJ Qual Saf. 2021;30(2):96–105. doi:10.1136/bmjqs-2019-010206
   PubMed Web of Science ®Google Scholar
• Mulac A, Taxis K, Hagesaether E, Granas AG. Severe and fatal medication errors in hospitals: findings from the Norwegian Incident Reporting System. Eur J Hosp Pharm. 2021;28(e1):e56–e61.
   PubMedGoogle Scholar
• Abiri OT, Johnson WCN. Pharmacovigilance systems in resource-limited settings: an evaluative case study of Sierra Leone. J Pharm Policy Pract. 2019;12:13. doi:10.1186/s40545-019-0173-2
   PubMed Web of Science ®Google Scholar
• Isah AO, Pal SN, Olsson S, Dodoo A, Bencheikh RS. Specific features of medicines safety and pharmacovigilance in Africa. Ther Adv Drug Saf. 2012;3(1):25–34. doi:10.1177/2042098611425695
   PubMedGoogle Scholar
• Coker J, Bawoh M, Lahai M, Abiri O, Mambu T, Lisk D. Adherence to a standard prescription writing guidelines in a Tertiary Hospital in Sierra Leone. Int J Sci Res. 2021;10(2):177–180.
   Google Scholar
• Geoffrey CU, Plou S. Research randomizer 1997–2021. Available from: https://www.randomizer.org. Accessed April 25, 2021.).
   Google Scholar
• N JG. Audit of medical prescriptions writing compliance with essential medicines list standards in the outpatient Department of South Rand Hospital, Johannesburg: a quality improvement project. Unpublished report. Johannesburg: Department of Family Medicine, University of the Witwatersrand; 2013.
   Google Scholar
• Patel NM, Vaniya HV, Agrawal JM, Balat JD, Singh AP, Trivedi HR. Adverse drug reaction monitoring on antiretroviral therapy in human immunodeficiency virus patients in a tertiary care hospital. Int J Basic Clin Pharmacol. 2015;4:907–911. doi:10.18203/2319-2003.ijbcp20150864
   Google Scholar
• Hassan NB, Ismail HC, Naing L, Conroy RM, Abdul Rahman AR. Development and validation of a new prescription quality index. Br J Clin Pharmacol. 2010;70(4):500–513. doi:10.1111/j.1365-2125.2009.03597.x
   PubMed Web of Science ®Google Scholar
• Drug.com. Drug interactions checker 2000–2022. Available from: https://www.drugs.com/drug_interactions.html. Accessed July 1, 2021.
   Google Scholar
• Mishra S, Pathak PK, Ahmad S, et al. Quality of prescription writing practices in a Tertiary Care Teaching Hospital of Bihar: a Cross-Sectional Study. Int J Health Syst Implement Res. 2020;4(2):24–33.
   Google Scholar
• Oshikoya K, Chukwura H, Ojo O. Evaluation of outpatient pediatric drug prescriptions in a teaching hospital in Nigeria for rational prescribing. Pediatr Perinat Drug Ther. 2006;7(4):183. doi:10.1185/146300906X167728
   Google Scholar
• Mohammed-Jawad NK, Abdulrahman NM, Emad A, Jumaa S. Assessment of dosing errors in pediatric patients prescriptions in Basra city. Arch Pharm Pract. 2020;11(1):73–76.
   Web of Science ®Google Scholar
• Callaghan LC. Prescribing in pediatric obesity: methods to improve dosing safety in weight-based dose calculations. Arch Dis Child Educ Pract. 2018;103(5):274–277. doi:10.1136/archdischild-2016-311491
   Google Scholar
• O’Hara K. Paediatric pharmacokinetics and drug doses. Austr Prescr. 2016;39(6):208. doi:10.18773/austprescr.2016.071
   PubMedGoogle Scholar
• Lim SY, Pettit RS. Pharmacokinetic considerations in pediatric pharmacotherapy. Am J Health Syst Pharm. 2019;76(19):1472–1480. doi:10.1093/ajhp/zxz161
   PubMed Web of Science ®Google Scholar
• Bereda G. Pediatrics pharmacokinetics and dose calculation. J Pediatr Neonatal Cares. 2022;12:96–102. doi:10.15406/jpnc.2022.12.00463
   Google Scholar
• Wimmer S, Toni I, Botzenhardt S, Trollmann R, Rascher W, Neubert A. Impact of a computerized physician order entry system on medication safety in pediatrics—The AVOID study. Pharmacol Res Perspect. 2023;11(3):e01092. doi:10.1002/prp2.1092
   PubMed Web of Science ®Google Scholar
• Bates DW. Preventing medication errors: a summary. Am J Health Syst Pharm. 2007;64(14_Supplement_9):S3–S9. doi:10.2146/ajhp070190
   PubMedGoogle Scholar
• Khaemba CN. Incidence and determinants of medication errors among paediatric inpatients at Kisii level 5 hospital. Doctoral dissertation; University of Nairobi. Available from: http://erepository.uonbi.ac.ke/handle/11295/76448. Accessed April 25, 2021.
   Google Scholar
• Fekadu G, Abdisa E, Fanta K. Medication prescribing errors among hospitalized pediatric patients at Nekemte Referral Hospital, western Ethiopia: a cross-sectional study. BMC Res Notes. 2019;12(1):1–6. doi:10.1186/s13104-019-4455-1
   PubMedGoogle Scholar
• Zeleke A, Chanie T, Woldie M. Medication prescribing errors and associated factors at the pediatric wards of Dessie Referral Hospital, Northeast Ethiopia. Int Arch Med. 2014;7(1):1–6. doi:10.1186/1755-7682-7-18
   PubMedGoogle Scholar
• Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001;285(16):2114–2120. doi:10.1001/jama.285.16.2114
   PubMed Web of Science ®Google Scholar
• Lalande J, Vrignaud B, Navas D, et al. A prospective observational study of medication errors in a pediatric emergency department. Arch Pediatr. 2018;25(6):355–358. doi:10.1016/j.arcped.2018.06.005
   PubMed Web of Science ®Google Scholar
• Drovandi A, Robertson K, Tucker M, Robinson N, Perks S, Kairuz T. A systematic review of clinical pharmacist interventions in pediatric hospital patients. Eur J Pediatr. 2018;177:1139–1148. doi:10.1007/s00431-018-3187-x
   PubMed Web of Science ®Google Scholar
• Lubinga S, Uwiduhaye E. Potential drug-drug interactions on in-patient medication prescriptions at Mbarara Regional Referral Hospital (MRRH) in western Uganda: prevalence, clinical importance and associated factors. Afr Health Sci. 2011;11(3):499–507.
   PubMed Web of Science ®Google Scholar
• Moura C, Prado N, Acurcio F. Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study. Clin Drug Invest. 2011;31:309–316. doi:10.1007/BF03256929
   PubMed Web of Science ®Google Scholar
• Walsh EK, Hansen CR, Sahm LJ, Kearney PM, Doherty E, Bradley CP. Economic impact of medication error: a systematic review. Pharmacoepidemiol Drug Saf. 2017;26(5):481–497. doi:10.1002/pds.4188
   PubMed Web of Science ®Google Scholar
• Tan-Koi WC, Limenta M, Mohamed EH, Lee EJ. The importance of ethnicity definitions and pharmacogenomics in ethnobridging and pharmacovigilance. In: Pharmacogenomics. Academic Press; 2019:289–327.
   Google Scholar
• Qorraj-Bytyqi H, Hoxha R, Krasniqi S, Bahtiri E, Kransiqi V. The incidence and clinical relevance of drug interactions in pediatrics. J Pharmacol Pharmacotherapeutics. 2012;3(4):304. doi:10.4103/0976-500X.103686
   PubMedGoogle Scholar
• Hassanzad M, Tashayoie Nejad S, Mahboobipour AA, Salem F, Baniasadi S. Potential drug-drug interactions in hospitalized pediatric patients with respiratory disorders: a retrospective review of clinically important interactions. Drug Metab Pers Ther. 2020;35(1):20190012.
   Google Scholar
• Langerová P, Prokeš M, Konvalinka M, Fürstová J, Urbánek K. Incidence of potential drug interactions in medication prescriptions for children and adolescents in the University Hospital Olomouc, Czech Republic. Eur J Pediatr. 2013;172:631–638. doi:10.1007/s00431-013-1933-7
   PubMed Web of Science ®Google Scholar
• Ahmed S, Yesmine S, Rahman M, Shahriar M. Assessment of interactions of drugs prescribed for pediatric patients in Bangladesh. Bangladesh Pharm J. 2021;24(2):91–98. doi:10.3329/bpj.v24i2.54706
   Google Scholar
• Mistry M, Gor A, Ganguly B. Potential drug-drug interactions among prescribed drugs in the pediatric outpatients department of a tertiary care teaching hospital. J Young Pharm. 2017;9(3):371. doi:10.5530/jyp.2017.9.74
   Google Scholar
• Costa HT, Leopoldino RWD, da Costa TX, Oliveira AG, Martins RR. Drug–drug interactions in neonatal intensive care: a prospective cohort study. Pediatr Neonatol. 2021;62(2):151–157. doi:10.1016/j.pedneo.2020.10.006
   PubMed Web of Science ®Google Scholar
• Ahmadi M, Nazemi A, Davoodpour SF, Gharaie Pour F, Montaseri M, Safa O. A retrospective and cross-sectional study to evaluate potential drug–drug interaction in hospitalized pediatrics, Bandar Abbas, Iran. Trends Pharmacol Sci. 2018;4(4):241–248.
   Google Scholar
• Bibi S, Chisti MJ, Akram F, Pietroni MA. Ampicillin and gentamicin are a useful first-line combination for the management of sepsis in under-five children at an urban hospital in Bangladesh. J Health Popul Nutr. 2012;30(4):487–490. doi:10.3329/jhpn.v30i4.13418
   PubMed Web of Science ®Google Scholar
• Pickering LK, Rutherford I. Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin. J Pharmacol Exp Ther. 1981;217(2):345–349.
   PubMed Web of Science ®Google Scholar
• Viollier A-F, Standiford HC, Drusano GL, Tatem BA, Moody MR, Schimpff SC. Comparative pharmacokinetics and serum bactericidal activity of mezlocillin, ticarcillin, and piperacillin, with and without gentamicin. J Antimicrob Chemother. 1985;15(5):597–606. doi:10.1093/jac/15.5.597
   PubMed Web of Science ®Google Scholar
• Kradjan WA, Burger R. In vivo inactivation of gentamicin by carbenicillin and ticarcillin. Arch Intern Med. 1980;140(12):1668–1670. doi:10.1001/archinte.1980.00330230114024
   PubMedGoogle Scholar
• Le TA, Hiba T, Chaudhari D, et al. Aminoglycoside-related nephrotoxicity and ototoxicity in clinical practice: a review of pathophysiological mechanism and treatment options. Adv Ther. 2023;40(4):1357–1365. doi:10.1007/s12325-023-02436-x
   PubMed Web of Science ®Google Scholar
• Rostom A, Muir K, Dube C, Lanas A, Jolicoeur E, Tugwell P. Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. Drug Healthc Patient Saf. 2009;47–71. doi:10.2147/DHPS.S4334
   PubMedGoogle Scholar
• Maideen NM, Balasubramanian R, Muthusamy S. A comprehensive review of the pharmacologic perspective on loop diuretic drug interactions with therapeutically used drugs. Curr Drug Metab. 2022;23(3):188–199. doi:10.2174/1389200223666220401092112
   PubMed Web of Science ®Google Scholar
• Getachew H, Assen M, Dula F, Bhagavathula AS. Potential drug–drug interactions in pediatric wards of Gondar University Hospital, Ethiopia: a cross-sectional study. Asian Pac J Trop Biomed. 2016;6(6):534–538. doi:10.1016/j.apjtb.2016.04.002
   Web of Science ®Google Scholar